Investigating treatment effects on cartilage lesions during hallux valgus surgery
Official title: Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions
Run by Algemeen Ziekenhuis Maria Middelares · NCT04716140 · Data updated 2026-11-12
This study is testing if treating cartilage damage during surgery for bunions helps patients feel better after their operation compared to those who don’t get the treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 60 Years |
| Sex | All |
| Enrollment | 99 (estimated) |
| Sponsor | Algemeen Ziekenhuis Maria Middelares Academic / other |
| Locations | 1 site (Ghent) |
| Status | Recruiting |
| Started | September 15, 2020 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | March 12, 2025 |
| Trial ID | NCT04716140 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 30 to 60 years who are scheduled for hallux valgus surgery.
✕Probably not a fit
Patients with additional pathologies other than hallux valgus or those outside the age range may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the impact of treating cartilage lesions at the first metatarsophalangeal joint during corrective surgery for hallux valgus. It involves a randomized approach where patients are divided into two groups: one group will not receive treatment for cartilage lesions, while the other group will have their lesions treated through debridement and microfracture. The severity of cartilage lesions will be assessed using the ICRS scale and MS Hololens technology. Participants will complete questionnaires to assess their clinical outcomes pre- and post-surgery.
Why it matters
Potential benefit: If successful, this study could provide insights into the optimal management of cartilage lesions during hallux valgus surgery, potentially improving patient outcomes.
How similar studies have gone: While there is limited literature on this specific approach, the study aims to fill a gap in understanding the treatment of cartilage lesions in this context, indicating a novel investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * hallux valgus Exclusion Criteria: * younger than 30 years, older than 60 years * extra pathologies other than hallux valgus
Where it's running
-
AZ Maria Middelares
Ghent, Belgium Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Self-rehabilitation after foot surgery with a connected app
This study tests whether a connected rehabilitation app can help adults after hallux valgus surgery improve ankle and toe mobility at home.
-
Sciatic nerve block with extended-release bupivacaine (ALX006) for bunion surgery
This will test whether a single-dose extended-release bupivacaine (ALX006) given as a sciatic nerve block reduces pain after bunion surgery in adults.
-
VIRTUGUIDE System with DePuy Synthes Lapidus Implant for Hallux Valgus
This study tests how well the VIRTUGUIDE System with a compatible DePuy Synthes Lapidus implant works for people undergoing a primary Lapidus procedure to correct hallux valgus.
-
Platelet-Rich Plasma from Two Different Systems in Knee Osteoarthritis
This study compares PRP made by two FDA-approved machines to see if the platelets differ and whether injections help knee symptoms.
-
One versus two Kirschner wires for minimally invasive correction of severe hallux valgus
This trial tests whether adding a second Kirschner (K-) wire during minimally invasive bunion surgery helps people with severe hallux valgus keep their toe alignment and have fewer complications.
-
Agar and undenatured type II collagen for easing knee and joint pain
This trial will try whether daily agar-agar, undenatured type II collagen, or their combination reduces knee pain in adults aged 40–70 with mild to moderate knee pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.